← Back to headlines
Merck's Acquisition of Terns Therapeutics Clears HSR Waiting Period
Merck's proposed acquisition of Terns Therapeutics has successfully passed the expiration of the Hart-Scott-Rodino (HSR) antitrust waiting period, moving the deal closer to completion.
24 Apr, 13:18 — 24 Apr, 13:18
Sources
Showing 1 of 1 sources
Related Stories
Actress Busy Philipps Reveals Diagnosis and Recovery from Rare Brain Tumor
14m ago
Closing Arguments Approach in Murder Trial of Mother Accused of Killing Three Children
31m ago
New Zealand’s Starship Hospital Defers Non-Urgent Cases Amid Pediatric Flu Surge
35m ago
EU Approves Revolutionary Pancreatic Cancer Treatment Improving Survival Rates
45m ago